AUSTIN, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Swarmer, Inc (“Swarmer”) (Nasdaq: SWMR), a drone autonomy software company which has supported more than 100,000 real-world combat missions in Ukraine since April 2024, will hold a conference call and webcast on Wednesday, May 13, 2026, at 9:00 a.m. Eastern time (6:00 a.m. Pacific time) to discuss its financial results for the quarter ended March 31, 2026. Financial results will be issued in a press release prior to the call. Swarmer management will host the ...

NASHVILLE, Tenn., April 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the first quarter ended March 31, 2026. In addition, the Company announced an increased 2026 Normalized FFO guidance range of $1.59 to $1.65 per share (diluted), a $0.01 increase at the midpoint, and an increased Same Store Cash NOI growth guidance range of 3.75% to 4.75% (+25bps increase). FIRST QUARTER 2026 HIGHLIGHTS GAAP Net loss of $(0.00) per share, NAREIT FFO of $0.35 per sh ...

First quarter 2026 revenue grew 6% and recurring revenue grew 7% from the first quarter of 2025MINNEAPOLIS, April 30, 2026 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), the leading intelligent supply chain network, today announced financial results for the first quarter ended March 31, 2026. Financial Highlights First Quarter 2026 Financial Highlights Revenue was $192.1 million in the first quarter of 2026, compared to $181.5 million in the first quarter of 2025, reflecting 6% growth.Recurring reve ...

Revenue increased by 11% to $1.4 billion; up 8% on a constant currency basis GAAP gross margin up 290 bps to 62.2%; non-GAAP gross margin up 290 bps to 62.8%GAAP income from operations increased 17%; non-GAAP income from operations up 18%GAAP diluted earnings per share of $2.74; non-GAAP diluted earnings per share of $2.86Operating cash flow of $554 million; $262 million returned to shareholders through share repurchases and dividends Note: A webcast of Resmed’s conference call will be available at 4:30 p.m ...

Fifth Agreement Reflects Accelerating Demand for Integrated Clearing PlatformTAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (NYSE American: ATCH) ("AtlasClear" or the "Company"), a technology-enabled financial services platform, today announced the execution of its fifth correspondent broker-dealer agreement through Wilson-Davis & Co., Inc., AtlasClear's wholly owned correspondent-clearing broker-dealer subsidiary. The new agreement extends a pipeline of correspondent relationship ...

Ongoing Phase 1b human challenge study with oral, direct-acting protease inhibitor is designed to demonstrate proof-of-concept as a preventive and a treatmentFully enrolled first cohort is assessing the infectivity of the human challenge inoculumThere are no approved treatments or vaccines for norovirus, the leading cause of acute gastroenteritis across all age groups and geographies with a $60 billion annual economic burdenFDA Fast Track designation granted for CDI-988 underscores the lack of approved ther ...

TULSA, Okla., April 30, 2026 (GLOBE NEWSWIRE) -- Matrix Service Company (Nasdaq: MTRX) (“Matrix” or the “Company”), a leading provider of engineering and construction services to the energy and industrial markets, today announced that Kevin Cavanah, Vice President of Finance and Chief Financial Officer, will depart the Company following the filing of the Company’s fiscal 2026 Annual Report. He will continue to serve in his role as Chief Financial Officer through that time to support an orderly transition. M ...

SAN FRANCISCO, April 30, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2026. First Quarter 2026 Financial Highlights Revenue of $199.4 million, a 25.7% increase compared to first quarter 2025Gross margin of 70.9%, a 210-basis point increase compared to first quarter 2025Net loss of $13.9 million, a $16.8 ...

文章核心观点 - Strata Critical Medical公司已完成对区域灌注服务提供商Ohio Valley Perfusion Associates的收购 此次收购旨在加强公司在俄亥俄州东部和宾夕法尼亚州西部的区域临床平台 并与现有业务形成协同 [1][2] 收购交易细节 - 交易收购价格约为100万美元 [2] - 收购的估值倍数具有吸引力 为EBITDA的中个位数倍数 符合公司的目标估值框架 [2] - 此次收购被公司定义为一次“补强收购” 与现有临床运营和并购战略完美契合 [2] 收购标的业务概况 - 被收购方Ohio Valley Perfusion Associates是一家区域灌注服务提供商 服务于俄亥俄州和宾夕法尼亚州的客户 [1][2] - 该公司提供灌注及相关服务 包括ECMO（体外膜肺氧合）和自体输血 [2] - 该公司拥有一支由8名训练有素且持有认证的临床医生组成的团队 [2] 战略与业务协同 - 收购将扩大公司在东部俄亥俄州和西部宾夕法尼亚州的业务存在 [2] - 被收购业务与公司现有运营高度契合 使公司能进一步利用其训练有素的灌注师团队来支持心脏外科项目 [2] - 通过合作 被收购团队将获得额外的临床资源、技术和基础设施 从而能够扩展服务并更好地支持该地区的医院合作伙伴 [2] 行业与市场机会 - 心脏灌注业务具有多项极具吸引力的属性 包括经常性收入、多年期合同、高客户保留率 并且该行业仍然呈现碎片化状态 [2] - 除了专注于发展移植相关业务外 公司也将心脏灌注视为一个有吸引力的平台 未来几年可通过内生增长和收购实现扩张 [2] 公司主营业务介绍 - Strata Critical Medical是一家为美国医疗保健行业提供时效性关键物流和医疗服务的供应商 [3] - 公司运营着全美最大的航空运输和外科服务网络之一 服务于移植医院和器官获取组织 为供体器官恢复提供集成的“一站式”解决方案 [3] - 核心服务包括为移植行业提供的空中和地面物流、外科器官恢复、器官安置和区域性常温灌注 以及为心血管手术中心提供的灌注人员配备和设备解决方案 相关服务通过Trinity Medical Solutions和Keystone Perfusion品牌提供 [4]

公司近期活动 - Nyxoah SA 将参加美国银行2026年医疗健康会议，计划于2026年5月13日美国东部时间下午5:15进行网络直播演示 [1] - 公司将在会议期间与参会的机构投资者举行一对一会议 [2] 公司业务与产品 - Nyxoah 是一家专注于开发和商业化治疗阻塞性睡眠呼吸暂停（OSA）创新解决方案的医疗技术公司 [1][3] - 公司的核心解决方案是 Genio 系统，这是一种以患者为中心、无导线、无需电池的舌下神经刺激疗法，用于治疗OSA [3] - OSA 是全球最常见的睡眠呼吸障碍，与死亡风险和心血管合并症增加相关 [3] 产品监管与临床进展 - Genio 系统在成功完成 BLAST OSA 研究后，于2019年获得欧洲CE标志 [4] - 基于 BETTER SLEEP 研究的积极结果，公司获得了CE标志批准，将其治疗适应症扩展至完全同心塌陷（CCC）患者，而该病症目前是竞争疗法的禁忌症 [4] - 公司宣布了 DREAM IDE 关键研究的积极结果，并于2025年8月获得美国FDA批准，用于治疗呼吸暂停低通气指数（AHI）大于等于15且小于等于65的中重度成年OSA患者子集 [4][5]